Predicting TKI Efficacy in Cancer Through a Single-Cell-Guided Model of Kinase Activation

A computational system for prioritizing tyrosine kinase inhibitors (TKIs) by integrating single‑cell transcriptional data, advanced computational modeling, and machine‑learning–based scoring to identify tumor‑specific signaling vulnerabilities across the entire tumor microenvironment.

Loading icon